Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections

Huang, DB, Corey, GR, Holland, TL et al. (8 more authors) (2018) Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections. International Journal of Antimicrobial Agents, 52 (2). pp. 233-240. ISSN 0924-8579

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: (c) 2018, Elsevier Ltd. All rights reserved. This is an author produced version of a paper published in International Journal of Antimicrobial Agents. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: Iclaprim; Vancomycin; Acute bacterial skin and skin-structure infection
Dates:
  • Published: August 2018
  • Accepted: 12 May 2018
  • Published (online): 19 May 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 22 May 2019 09:03
Last Modified: 22 May 2019 09:03
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.ijantimicag.2018.05.012
Related URLs:

Share / Export

Statistics